International Congress of the International Society of Blood Transfusion. Oslo, NOR, 1998/06/27.
Although hemovigilance is not a word used conunonly in the United States, the concept of monitoring morbidity associated with blood transfusion is accepted widely.
Currently, quality management focuses on error avoidance rather than error detection in both the « manufacturing'and » clinical « aspects of blood banking. » Manufacturing'is regulated predominantly by current Good Manufacturing Practices while clinical transfusion medicine follows clinical practice guidelines.
There are multiple overlapping mechanisms for quality assurance and error reporting among governmental, professional, and non-profit regulatory agencies.
The strategies of each stress the on-going need for a systems approaches to preventing errors.
Mots-clés Pascal : Homme, Transfusion, Sang, Assurance qualité, Etats Unis, Amérique du Nord, Amérique, Liquide biologique
Mots-clés Pascal anglais : Human, Transfusion, Blood, Quality assurance, United States, North America, America, Biological fluid
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0454503
Code Inist : 002B27D01. Création : 25/01/1999.